Belpointe Asset Management LLC Gilead Sciences, Inc. Transaction History

Belpointe Asset Management LLC

$1.24 Billion
Q1 2024

A detailed history of Belpointe Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Belpointe Asset Management LLC holds 11,006 shares of GILD stock, worth $733,990. This represents 0.07% of its overall portfolio holdings.

Number of Shares

11,006

Previous 10,448 5.34%

Holding current value

$733,990

Previous $846,000 4.73%

% of portfolio

0.07%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $39,941 - $48,707	558 Added 5.34%	11,006 $806,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $65,723 - $74,531	-897 Reduced 7.91%	10,448 $846,000
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $268,550 - $292,993	3,632 Added 47.09%	11,345 $850,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $1.12 Million - $1.27 Million	-14,674 Reduced 65.55%	7,713 $594,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $561,811 - $640,077	-7,267 Reduced 24.51%	22,387 $1.86 Million

Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $378,531 - $543,440	-6,074 Reduced 17.0%	29,654 $2.55 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $19,588 - $22,375	-329 Reduced 0.91%	35,728 $2.21 Million
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $242,077 - $272,651	4,194 Added 13.16%	36,057 $2.23 Million
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $524,928 - $657,792	9,063 Added 39.75%	31,863 $1.89 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $158,631 - $180,049	2,445 Added 12.01%	22,800 $1.66 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $28,700 - $30,964	-424 Reduced 2.04%	20,355 $1.42 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $120,910 - $132,111	1,905 Added 10.09%	20,779 $1.43 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $186,420 - $212,705	-3,107 Reduced 14.13%	18,874 $1.22 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $487,076 - $555,000	8,598 Added 64.25%	21,981 $1.28 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $371,171 - $466,684	-5,977 Reduced 30.87%	13,383 $846,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $386,199 - $485,579	6,219 Added 47.33%	19,360 $1.45 Million
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $449,882 - $522,396	-6,219 Reduced 32.12%	13,141 $1.01 Million
Q1 2020 Jul 20, 2020	BUY	$62.63 - $80.22 $395,946 - $507,150	6,322 Added 48.49%	19,360 $1.45 Million
Q4 2019 Feb 18, 2020	BUY	$61.62 - $67.78 $57,368 - $63,103	931 Added 7.69%	13,038 $847,000
Q3 2019 Jan 16, 2020	SELL	$62.51 - $69.0 $142,710 - $157,527	-2,283 Reduced 15.87%	12,107 $767,000
Q2 2019 Nov 22, 2019	BUY	$61.87 - $69.38 $375,303 - $420,859	6,066 Added 72.87%	14,390 $0
Q1 2019 Jun 11, 2019	SELL	$62.53 - $70.05 $223,669 - $250,568	-3,577 Reduced 30.06%	8,324 $541,000
Q4 2018 Mar 06, 2019	BUY	$60.54 - $79.0 $272,853 - $356,053	4,507 Added 60.95%	11,901 $744,000
Q3 2018 Nov 23, 2018	BUY	$71.28 - $78.92 $71,778 - $79,472	1,007 Added 15.77%	7,394 $571,000
Q2 2018 Aug 06, 2018	BUY	$64.88 - $75.68 $85,446 - $99,670	1,317 Added 25.98%	6,387 $452,000
Q1 2018 Aug 06, 2018	SELL	$72.84 - $88.8 $74,005 - $90,220	-1,016 Reduced 16.69%	5,070 $382,000
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $11,597 - $13,613	163 Added 2.75%	6,086 $436,000
Q3 2017 Nov 16, 2017	BUY	$72.11 - $85.47 $427,107 - $506,238	5,923	5,923 $480,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Gilead Sciences, Inc. Transaction History